Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time
July 22, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System
July 16, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt
July 10, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser
June 24, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Appoints Bob MacDonald as Chief Retail Officer
June 10, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System
June 04, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 04, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering
May 23, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 23, 2019 (GLOBE NEWSWIRE) -- OBALON THERAPEUTICS, INC. (NASDAQ: OBLN) (“Obalon” or the “Company”), a vertically integrated medical technology company with the first and only...
Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019
May 21, 2019 16:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Receipt of Delisting Notification Letters from Nasdaq
May 17, 2019 16:01 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 17, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Engages Cowen to Explore Financial and Strategic Alternatives
April 11, 2019 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...